The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trial

Autor: Kao, Dina *, Wong, Karen, Franz, Rose, Cochrane, Kyla, Sherriff, Keith, Chui, Linda, Lloyd, Colin, Roach, Brandi, Bai, Anthony D, Petrof, Elaine O, Allen-Vercoe, Emma
Zdroj: In The Lancet Gastroenterology & Hepatology April 2021 6(4):282-291
Databáze: ScienceDirect